voltage had evidence of paraprosthetic regurgitation and minimal change in CSA. Three other patients with persistent LV enlargement without paraprosthetic regurgitation had a severe intraventricular conduction delay. Data from 59 electrocardiographic-echocardiographic studies before and after AVR revealed a strong correlation (r = 0.81) between voltage and muscle CSA. After surgical correction of chronic aortic regurgitation, regression of LV hypertrophy can be assesed by serial electrocardiographic studies. These ECG data Identify patients with complete, incomplete or no regression of LV hypertrophy. ELECTROCARDIOGRAPHIC evidence of left ventricular hypertrophy (LVH) is generally associated with angiographic, echocardiographic, and autopsy evidence of increased LV myocardial mass.1-3 However, there is little ECG evidence to support the idea that regression of LVH is an expected consequence if the stimulus for hypertrophy is removed. After aortic valve replacement for chronic aortic regurgitation, LV mass may be reduced; a few patients achieve normal LV mass and others exhibit little or no regression of hypertrophy.' 12 The value of the ECG in assessing these structural changes has not been studied in detail. Therefore, we designed the present study to test the hypothesis that ECG voltage is related to LV mass in patients with chronic aortic regurgitation and that the extent of regression of LVH after aortic valve replacement is reflected by a commensurate decrease in ECG voltage.
Methods
Twenty-one patients who underwent aortic valve replacement for chronic aortic regurgitation between January 1975 and June 1979 participated in this study. Admission required pre-and postoperative ECGs and M-mode echocardiograms. Preoperatively, all 21 patients had typical clinical and hemodynamic findings of significant aortic regurgitation. Patients 18 and 20 developed paravalvular leaks (after a second operation these two are identified as patients 7 and 23). Patients 14 and 22 had associated coronary surgery (single graft to the left anterior descending coronary artery) and patient 17 had a right'ventricular transvenous pacemaker inserted postoperatively.
The ECGs were 12-lead tracings with standard instrument sensitivity (10 mm = mV). All available ECGs were analyzed by an experienced reader who had no knowledge of the clinical status of the patients. For each patient, representative preoperative and late postoperative (11'-13 months) ECGs were selected. Serial postoperative ECGs at 0.3, 3, 6, 9 and 12 months we're also analyzed when available. A sum of precordial voltage (SV1 + RV, or RV,, the Sokolow index) was used for the electrocardiographic diagnosis of LVH (SV1 +' RV6, > 35 mm). Serial tracings in individual patients were not compared if the QRS duration changed by more than 0.01 second, the mean QRS axis shifted by more than 300, a perioperative myocardial infarction occurred or left bundle branch block was present.
The patients were grouped according to changes in the postoperative ECGs. In group patients (n = 7), precordial voltage (SV1 + RV,,) decreased by at least 15% and was less than 35 mm at the late postoperative study. Group 2 patients (n = 8) also achieved at lea'st a 15% decrease in precordial voltage, but the SV1 + RV,, remained above 35 mm. Two patients had little or no change in precordial voltage (group 3), and three developed paravalvular regurgitation (group 4). In three additional patients (group 5), we did not measure precordial voltage because of the presence of preoperative left bundle branch block (patient 22), new left bundle branch block' after surgery (patient 23), and a new intraventricu-lar conduction defect with a 550 change in the mean QRS axis (patient 21). Serial data were examined only in groups 1 and 2.
Echocardiograms were obtained with a Smith Kline ultrasonoscope and a 2.25-MHz transducer. LV di-2 lOOr 801 (AD cn) 601 3 mension at end-diastole (DED) was measured at the R wave of the ECG and the dimension at end-systole (DES) was measured as the smallest vertical dimension between the left septal echo and the posterior wall endocardium at e'nd-systole. Posterior wall thickness (Th) was measured at end-diastole from the leading edge of the epicardial echo to the leading edge of the endocardial echo, with the gain adjustment set to minimize the width of these signals. Likewise, the septal thickness was measured from the leading edge of the right septal echoes to the leading edge of the left septal echoes: Fractional shortening (%AD) was expressed as the percent change in LV dimension from end-diastole to end-systole; DES and %AD were not determined when the septal motion was paradoxical or markedly hypokinetic (septal excursion < 2 mm).
Echocardiographic estimation of LV muscle mass is dependent on several assumptions regarding ventricular dimensions and geometry. We therefore used an index of LV myocardial mass that does not require major geometric assumptions." 13 This index, the cross-sectional area (CSA in cm2) of the LV wall in a transverse plane, was calculated from the echocardiographic dimension and wall thickness at end-diastole: CSA = 7r ([DED/2] + Th)2 -7r (DED/2)2 The pre-and postoperative ECG voltage and echocardiographic CSA data were analyzed by analysis of variance. Analysis of variance was used to determine whether significant differences existed between groups at the time of the preoperative and 12-month postoperative studies. Serial changes in ECG and echocardiographic data were evaluated with analysis of variance for paired observations.
Results
The electrocardiographic data are presented in table 1 and the echocardiographic data in table 2. -Precordial voltages before and after aortic valve replacement in the first four groups of patients are shown in given in millimeters (10 mm = 1 mV); the broken line at 35 mm indicates the upper limit of normal. Voltage declined by more than 15% in 15 of20 patients; seven achieved a normal voltage (group 1) and eight did not (group 2). Two patients with borderline preoperative voltage showed little change (group 3). Three patients with paraprosthetic regurgitation (group 4) had no change in voltage. seven (25 ± 6 mm, p < 0.001). All eight patients in group 2 had increased preoperative voltage (61 ± 17 mm); voltage declined by more than 15% postoperatively, (40 ± 4 mm, p < 0.005), but remained abnormal (> 35 mm). The mean value for the preoperative voltage was higher in group 2 (61 ± 17 mm) than in group 1 (48 ± 17 mm), but this difference did not achieve statistical significance. Two patients with borderline voltage in the preoperative study had little change in the postoperative study (group 3). Three patients who developed paravalvular regurgitation The time course of voltage reduction in groups I and 2 is shown in figure 2 , which excludes patients 4 and 15, who had only preoperative and 12-month postoperative ECGs. In group 1, the 9-month voltage was significantly less than the preoperative voltage (p < 0.005), as was the 12-month voltage (p < 0.001). In group 2, only the 12-month voltage was significantly less than the preoperative voltage (p < 0.005).
The preoperative CSA was increased in six of seven 19 20 (table 2) . Muscle CSA also declined in group 2 (15 ± 2 to 11 i 2 cm2/m2, p < 0.001), but it remained in the abnormal range (> 10 for all); the uncorrected CSA data from this group decreased from 28 2 cm2 to 22 + 4 cm2. Analysis of the serial CSA data indicate that the postoperative values in group 1 were not significantly different from preoperative values until 12 months; in group 2, both the 6-month (p < 0.005) and the 12-month (p < 0.001) CSA values were significantly less than the preoperative values. Postoperatively, the CSA was significantly less in group 1 (9 ± 1 cm2/m2) than in group 2 (11 ± 2 cm2/m2, p < 0.05), but there was no significant difference in the CSA of these two groups at the preoperative study.
The changes in voltage are plotted against changes in CSA in figure 3 . All patients in group 1 attained not only a normal voltage (< 35 mm), but CSA also decreased considerably after operation (. 10 mm). Seven of eight patients in group 2 achieved a parallel reduction in both voltage and CSA, but postoperative values in this group remained above normal.
Fifty-nine coordinates (all pre-and postoperative data) of voltage and CSA are plotted in figure 4 ; this figure does not include data from patients with left bundle branch block or from the single patient with voltage or mass (group 4). All three had typical aortic insufficiency murmurs, unchanged heart size and unimproved clinical status after aortic valve replacement. The lack of a significant decrease in voltage in these patients with unintentional sham operations indicates that nonhemodynamic factors associated with aortic valve surgery could not account for the voltage changes in the groups 1 and 2. Other factors that may prevent or limit the expected regression of hypertrophy include systemic arterial hypertension, patient-prosthesis mismatch resulting in LV outflow obstruction, or the presence of other cardiac lesions. Also, our data suggest that the amount of hypertrophy present preoperatively influences the extent to which hypertrophy regresses; patients who had incomplete regression of hypertrophy (group 2) tended to have larger preoperative voltage and mass than patients who had complete regression of LVH (group 1) (NS). Two patients with no postoperative change in voltage showed a reduction in LV mass (group 3). One, patient 17, had a permanent ventricular demand pacemaker implanted postoperatively, but whether intermittent right ventricular pacing could have influenced voltage is unknown. The second patient had a decrease in SV2, but there was no change in SV1 and thus the precordial voltage did not change. In the three patients in group 5, the use of voltage criteria for LV hypertrophy was precluded by the presence of an intraventricular conduction defect; two of the three had complete left bundle branch block. These three patients had a markedly increased LV end-diastolic dimension preand postoperatively.
We used precordial voltage because it is often used in clinical practice, is quantitative and can be easily measured and compared in serial studies. More complex methods make serial comparisons difficult and of unclear significance. Since we were most interested in serial changes in individual patients, high sensitivity and specificity for LV hypertrophy was not of paramount importance. We used CSA, an echocardiographic index of LV mass, because it does not have an inherent assumption regarding LV geometry. We and others have used this index to evaluate serial changes in LV mass.4 11 Despite the theoretical advantages and our preference for this index, we found the correlation coefficient between voltage and CSA (r = 0.81) to be similar to that between voltage and mass (r = 0.76, method of Devereux and Reichek14 15), There are practical advantages in using the ECG to evaluate the results of aortic valve replacement. Lack of regression of LV hypertrophy, manifested by persistently increased precordial voltage, should draw attention to the possibility of paraprosthetic regur-gitation, systemic hypertension, patient-prosthesis mismatch or the presence of other cardiac lesions. The reduction of precordial voltage to a normal level indicates regression of hypertrophy to a normal or nearly normal LV mass. Finally, the presence or development of a severe intraventricular conduction delay was seen only in patients with persistent LV enlargement. Although the clinical importance of this electrocardiographic abnormality is not clear, patients with persistent postoperative LV enlargement have a poor prognosis and should be identified so that aggressive medical therapy can be instituted. The simplicity, low cost, and wide familiarity of the ECG make it an excellent means to follow patients after surgical correction of chronic aortic regurgitation. 
